siRNA-mediated knockdown of Pdcd4 expression causes upregulation of p21(Waf1/Cip1) expression (Q81127317)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18427550%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

title

siRNA-mediated knockdown of Pdcd4 expression causes upregulation of p21(Waf1/Cip1) expression (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18427550%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

author name string

N Bitomsky

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18427550%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

N Wethkamp

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18427550%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

R Marikkannu

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18427550%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

K-H Klempnauer

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18427550%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

publication date

21 April 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18427550%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18427550%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

volume

27

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18427550%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

issue

35

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18427550%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

page(s)

4820-4829

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18427550%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/onc.2008.115

6 January 2020

exact match

0 references

cites work

Induction of PDCD4 tumor suppressor gene expression by RAR agonists, antiestrogen and HER-2/neu antagonist in breast cancer cells. Evidence for a role in apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.115

UV irradiation triggers ubiquitin-dependent degradation of p21(WAF1) to promote DNA repair

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.115

Transformation suppressor protein Pdcd4 interferes with JNK-mediated phosphorylation of c-Jun and recruitment of the coactivator p300 by c-Jun

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.115

Post-translational modification of p53 in tumorigenesis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.115

The transformation suppressor protein Pdcd4 shuttles between nucleus and cytoplasm and binds RNA.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.115

Synergistic activation of the chicken mim-1 gene by v-myb and C/EBP transcription factors.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.115

Loss of PDCD4 expression in human lung cancer correlates with tumour progression and prognosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.115

Differentially expressed protein Pdcd4 inhibits tumor promoter-induced neoplastic transformation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.115

S6K1- and betaTRCP-mediated degradation of PDCD4 promotes protein translation and cell growth

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.115

The cyclin-dependent kinase inhibitor p21CIP/WAF is a positive regulator of insulin-like growth factor I-induced cell proliferation in MCF-7 human breast cancer cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.115

WAF1, a potential mediator of p53 tumor suppression

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.115

Aberrant p21(CIP1/WAF1) protein accumulation in head-and-neck cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.115

DNA damage-inducible transcripts in mammalian cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.115

Lost in transcription: p21 repression, mechanisms, and consequences

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.115

DUG is a novel homologue of translation initiation factor 4G that binds eIF4A

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.115

Programmed cell death protein 4 suppresses CDK1/cdc2 via induction of p21(Waf1/Cip1)

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.115

Activation of p53 sequence-specific DNA binding by acetylation of the p53 C-terminal domain

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.115

The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.115

Negative regulation of the mammalian UV response by Myc through association with Miz-1

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.115

Translational regulation of autoimmune inflammation and lymphoma genesis by programmed cell death 4

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.115

Epidermal expression of the translation inhibitor programmed cell death 4 suppresses tumorigenesis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.115

New functional activities for the p21 family of CDK inhibitors

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.115

Programmed cell death protein 4 (pdcd4): a novel target for antineoplastic therapy?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.115

Structural basis for inhibition of translation by the tumor suppressor Pdcd4.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.115

31 March 2020

Birth of the D-E-A-D box

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.115

dapk1, encoding an activator of a p19ARF-p53-mediated apoptotic checkpoint, is a transcription target of p53.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.115

Continuous tissue culture cell lines derived from chemically induced tumors of Japanese quail

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.115

Loss of programmed cell death 4 expression marks adenoma-carcinoma transition, correlates inversely with phosphorylated protein kinase B, and is an independent prognostic factor in resected colorectal cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.115

Transcription factors control invasion: AP-1 the first among equals

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.115

Akt phosphorylates and regulates Pdcd4 tumor suppressor protein

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.115

31 March 2020

Why is p53 acetylated?

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.115

Bidirectional RNA helicase activity of eucaryotic translation initiation factors 4A and 4F

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.115

Myc suppression of the p21 Cip1 Cdk inhibitor influences the outcome of the p53 response to DNA damage

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.115

The chicken Pdcd4 gene is regulated by v-Myb

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.115

CDK inhibitors: positive and negative regulators of G1-phase progression

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.115

Isolation of a novel mouse gene MA-3 that is induced upon programmed cell death

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.115

p21 blocks irradiation-induced apoptosis downstream of mitochondria by inhibition of cyclin-dependent kinase-mediated caspase-9 activation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.115

Regulating the p53 pathway: in vitro hypotheses, in vivo veritas

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.115

Specific inhibition of gene expression using a stably integrated, inducible small-interfering-RNA vector

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.115

Downregulation of tumor suppressor Pdcd4 promotes invasion and activates both beta-catenin/Tcf and AP-1-dependent transcription in colon carcinoma cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.115

NMR assignment and secondary structure determination of the C-terminal MA-3 domain of the tumour suppressor protein Pdcd4

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.115

Structure of the C-terminal MA-3 domain of the tumour suppressor protein Pdcd4 and characterization of its interaction with eIF4A

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.115

p21Waf1/Cip1 as a therapeutic target in breast and other cancers

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.115

Suppression of breast cancer growth and angiogenesis by an antisense oligodeoxynucleotide to p21(Waf1/Cip1)

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.115

p21 is a universal inhibitor of cyclin kinases

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.115

A novel function of the MA-3 domains in transformation and translation suppressor Pdcd4 is essential for its binding to eukaryotic translation initiation factor 4A

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.115

The transformation suppressor Pdcd4 is a novel eukaryotic translation initiation factor 4A binding protein that inhibits translation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.115

A novel transformation suppressor, Pdcd4, inhibits AP-1 transactivation but not NF-kappaB or ODC transactivation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.115

Pdcd4 suppresses tumor phenotype in JB6 cells by inhibiting AP-1 transactivation.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.115

Tumorigenesis suppressor Pdcd4 down-regulates mitogen-activated protein kinase kinase kinase kinase 1 expression to suppress colon carcinoma cell invasion

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.115

ErbB2 overexpression in human breast carcinoma is correlated with p21Cip1 up-regulation and tyrosine-15 hyperphosphorylation of p34Cdc2: poor responsiveness to chemotherapy with cyclophoshamide methotrexate, and 5-fluorouracil is associated with Erb

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.115

Promising molecular targets for cancer prevention: AP-1, NF-kappa B and Pdcd4.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.115

AP2 inhibits cancer cell growth and activates p21WAF1/CIP1 expression

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.115